Overview
Feasibility of an Immediate Preoperative Chemotherapy Before Resection fo Colorectal Cancer
Status:
Terminated
Terminated
Trial end date:
2014-06-01
2014-06-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to analyze the clinical tolerance of immediate preoperative chemotherapy in terms of toxicity and perioperative morbidity and mortalityPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand ParisTreatments:
Folic Acid
Leucovorin
Levoleucovorin
Oxaliplatin
Criteria
Inclusion Criteria:- colorectal metastatic adenocarcinoma (stage IV) with unresectables, measurables and
visibles secondary lesions
- primitive tumor must be operate
- patient age between 18 and 70
- OMS status performance < 2
- life expectancy > 12 weeks
- hematologic function : PNN >/= 1.5x10^9/L, platelets >/= 100x10^9/L
- hepatic function : bilirubin = 1.5xLSN, AST and ALT = 3xLSN, alcalin phosphatasis
= 3xLSN
- plasmatimic creatin = 1.25xLSN
- No previous chemotherapy or pelvic radiotherapy
- men and women in age of procreate agreeing to use a contraception until 4 months after
the end of treatment for women and until 6 months for men
Exclusion Criteria:
- nonmetastatic forms
- Colorectal tumor which requires preoperative radiotherapy
- nonmeasurable metastasis based on RECIST criteria
- previous chemotherapy for colorectal cancer
- previous irradiation of the primitive tumour
- specific indication against the treatment studied
- Patient considered as inoperable for physiological or carcinologic reasons
- Pregnant or breast feeding women